Baxter International Inc said it agreed to purchase privately held Swedish dialysis product company Gambro AB for about $4 billion to boost its renal therapies portfolio. The deal, which is expected to close in the first half of 2013, will be financed through a combination of cash generated from overseas operations and debt.
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Shares of BAX remained unchanged at $65.80. In the past year, the shares have traded as low as $47.55 and as high as $68.91. On average, 3111020 shares of BAX exchange hands on a given day and today's volume is recorded at 0.
Source
